Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 05, 2026, titled "Zydus, MSN partner to Launch First Generic of Adempas® (Riociguat Tablets) in the U.S.".
Filed with NSE · ISIN INE010B01027 · · 3 pages · English
Earlier from Zydus Lifesciences
- Zydus Lifesciences Limited Press Release Oct 02 2026
- Zydus Lifesciences Limited Press Release Sep 30 2026
- Zydus Lifesciences Limited Press Release Sep 29 2026
- Zydus Lifesciences Limited Press Release Sep 28 2026